<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02371993</url>
  </required_header>
  <id_info>
    <org_study_id>F/N-R15-3427B</org_study_id>
    <nct_id>NCT02371993</nct_id>
  </id_info>
  <brief_title>Asthma in the Elderly: A Study of Choline Supplementation</brief_title>
  <official_title>Asthma in the Elderly: A Study of Choline Supplementation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Asthma in the elderly is poorly understood, as most studies have not included this patient
      group. In a previous study of adults with asthma, choline supplementation had a positive
      effect on asthma symptoms and allowed to decrease asthma pharmacologic treatment. The present
      study is a randomized, double-blind, placebo-controlled, cross-over study of choline
      supplementation. The investigators will study the effect of choline 650 mg taken orally twice
      daily x 6 weeks versus placebo on asthma symptom scores (Asthma Control Test) and spirometric
      values (FEV1, FEV1/FVC, FEF25-75%). The investigators will also look at the effect of choline
      supplementation on peripheral blood eosinophils, serum immunoglobulin E (IgE) and
      homocysteine levels.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of choline supplementation on asthma symptoms measured by the Asthma Control Test</measure>
    <time_frame>six weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of choline supplementation on spirometric values (FEV1, FEV1/FVC, FEF25-75%)</measure>
    <time_frame>six weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of choline supplementation on peripheral blood eosinophils</measure>
    <time_frame>six weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of choline supplementation on serum IgE</measure>
    <time_frame>six weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of choline supplementation on serum homocysteine levels</measure>
    <time_frame>six weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Asthma in the Elderly</condition>
  <arm_group>
    <arm_group_label>Choline 650 mg twice daily</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>See above</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>See above</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Choline</intervention_name>
    <arm_group_label>Choline 650 mg twice daily</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Choline 650 mg twice daily</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Asthma

        Exclusion Criteria:

          -  No history of smoking more than 10 pack/years,

          -  no gastrointestinal cancers,

          -  no liver or kidney disease,

          -  no bipolar disorder.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michele Columbo, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rohr and Columbo Asthma, Allergy and Immunology Specialists</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.</name>
      <address>
        <city>Bryn Mawr</city>
        <state>Pennsylvania</state>
        <zip>19010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2015</study_first_submitted>
  <study_first_submitted_qc>February 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2015</study_first_posted>
  <last_update_submitted>October 28, 2015</last_update_submitted>
  <last_update_submitted_qc>October 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.</investigator_affiliation>
    <investigator_full_name>Michele Columbo, M.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Choline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

